LGR5 and hepatocellular carcinoma: MiR-33a is downregulated in Lgr5+ HCC-CSCs, and restoring its expression with ectopic mimics could sensitize HCC to doxorubicin by directly targeting the drug efflux-related protein ABCA1 [31].